Results 61 to 70 of about 22,235 (205)

Invasive splenic mucormycosis due to Rhizopus microsporus during chemotherapy for acute monocytic leukemia: a case report and literature review

open access: yesFrontiers in Oncology, 2023
Mucormycosis is a rare opportunistic fungal infection associated with high mortality that typically occurs in immunocompromised patients. It is difficult to diagnose owing to non-specific clinical manifestations, the serologic index, imaging features ...
Xiru Peng   +4 more
doaj   +1 more source

Disease Entities in Mucormycosis

open access: yesJournal of Fungi, 2019
Mucormycosis is an emerging life-threatening fungal infection caused by Mucorales. This infection occurs mainly in immunocompromised patients, especially with hematological malignancy, transplantation, or diabetes mellitus.
Alexandra Serris   +2 more
doaj   +1 more source

Isolated pulmonary mucormycosis in diabetic patients

open access: yesJournal of Association of Pulmonologist of Tamil Nadu, 2023
Mucormycosis refers to the infection caused by a growing number of members of the Mucorales. Mucormycosis has emerged as an important opportunistic infection in severely immunocompromised patients with hematological malignancies and recipients of stem ...
Vyshnavi Rajeev   +3 more
doaj   +1 more source

Host‐Directed Biomaterials for Combatting Bloodstream Infections: From Macrocyclic Peptides to Immune‐Activating Cell Backpacks

open access: yesAdvanced Functional Materials, Volume 36, Issue 24, 23 March 2026.
Bloodstream infections (BSI) are one of the leading causes of mortality and morbidity in both civilian and military populations. This paper summarizes recent progress in novel treatment strategies to manage BSI arising from both bacterial and fungal pathogens using molecules, particles, and materials to elicit host‐directed immunity.
Thomas Thomou   +11 more
wiley   +1 more source

Transdiaphragmatic Mucormycosis

open access: yesClinical Infectious Diseases, 2019
Abstract Mucormycosis is a life-threatening infection. This is the first report of transdiaphragmatic mucormycosis in a series of 3 patients. We observed this phenomenon in 11% of patients. Clinicians should be aware of this possibly underreported entity, and as a consequence we envision more comprehensive imaging studies in patients ...
Philipp Koehler   +4 more
openaire   +2 more sources

Pulmonary embolism and gastric bleed with disseminated mucormycosis - treading dangerous waters

open access: yesMonaldi Archives for Chest Disease, 2022
Mucormycosis is an opportunistic infection seen in immunocompromised patients or in surgical and trauma settings with Mucorales wound contamination. In immunocompetent people, disseminated mucormycosis is uncommon.
Nishant Kumar Chauhan   +4 more
doaj   +1 more source

Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan [PDF]

open access: yes, 2011
Background Risk factors and outcomes in hematological patients who acquire invasive fungal sinusitis (IFS) are infrequently reported in the modern medical era.
Chien-Yuan Chen   +8 more
core   +2 more sources

Gastrointestinal mucormycosis

open access: yesJournal of British Surgery, 1991
Abstract Twenty patients with gastrointestinal mucormycosis are reviewed. This often fatal opportunistic fungal infection was diagnosed histologically, and was categorized as colonization (five patients), infiltration (seven patients), or vascular invasion (eight patients). There were no fatalities from colonization.
S R, Thomson   +3 more
openaire   +2 more sources

Demystifying fungal systematics: A gateway to fungal literacy and societal/ecological relevance through familiar species

open access: yesPLANTS, PEOPLE, PLANET, Volume 8, Issue 2, Page 499-515, March 2026.
Fungal systematics can feel overwhelming given the vast species diversity within this kingdom, with numerous subgroups at every taxonomic rank. This often creates a disconnect between the undertsnidng of fungal taxonomic diversity and their societal relevance.
Anna Vaiana   +4 more
wiley   +1 more source

Associated risk factors for post−COVID−19 mucormycosis at a tertiary care centre: A cross−sectional study

open access: yesJournal of Acute Disease, 2022
Objective: To explore risk factors of mucormycosis in COVID-19 recovered patients. Methods: A total of 101 patients, who were diagnosed with mucormycosis after recovery from COVID-19 and admitted to the Indira Gandhi Institute of Medical Sciences, Patna,
Praphull Deepankar   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy